JPRN-UMIN000007463已完成未知
Combination effects of an angiotensin receptor blocker and an L/T type calcium channel blocker in hypertensive patients with type 2 diabetes mellitus - COmbination Effects of an angiotensin receptor blocker and an L/T type calcium chaNnel blocker in hypertensive patients with type 2 diabetes mellitus (COEN)
agoya City University Graduate School of Medical Sciences0 个研究点目标入组 80 人开始时间: 2012年3月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Previous acute coronary syndrome, myocardial infarction, or stroke within 6 months; malignant neoplasm; heart failure (=>NYHA 2); peripheral artery disease (=>Fontaine 2); chronic inflammatory disease; hepatic disorder; estimated glomerular filtration rate <30 ml/min/1.73m2; contraindication to calcium channel blockers
研究者
相似试验
尚未招募
不适用
Effect of combination therapy of angiotensin receptor antagonist with calcium antagonist or with diuretics on left ventricular hypertrohyhypertensive cardiac hypertrophyJPRN-UMIN000004176Division of Cardiovacular Medicine, Wakayama Medical University60
招募中
1 期
Impact of a treatment with angiotensin receptor blocker on outcome after acute kidney injury in patients discharged from the ICU START-or-NOT trial”.A prospective, randomized, double blinded, multicenter studyEUCTR2020-000414-16-FRAPHP500
进行中（未招募）
不适用
Effects of an ARB on Microcirculation in Essential HypertensioEssential hypertensionMedDRA version: 14.1Level: LLTClassification code 10004254Term: Benign essential hypertensionSystem Organ Class: 10047065 - Vascular disordersEUCTR2008-005432-32-GBSt. George's University of London (SGUL)46
已完成
不适用
Influence of angiotensin receptor blocker and angiotensin-Converting Enzyme on renin-angiotensin-aldosterone system and left ventricular remodeling after cardiac surgerymyocardial infarction, anginaJPRN-UMIN000001464ihon University School of Medicine200
已完成
不适用
Efficacy of combination tablet of angiotensin receptor blocker and high dose calcium channel blocker in essential hypertensiopatients with essential hypertensionJPRN-UMIN000016704Tokyo Women's Medical University30